A
$ Value
—
Shares
8,170
Price
—
Filed
Feb 26
Insider
Name
Ellingson Rachel
Title
—
CIK
0001557271
Roles
Director
Transaction Details
Transaction Date
2026-02-24
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
57,995
Footnotes
The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026
Filing Info
Ellingson Rachel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-24 | BLFS | A | — |
Other Insiders at BLFS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
DE GREEF RODERICK
President and CEO
|
— | — | 2026-03-19 |
| GOSWAMI JOYDEEP | — | — | 2026-02-24 |
|
Mathew Aby J.
EVP & Chief Scientific Officer
|
— | $11K | 2026-04-08 |
| Hunt Anthony | — | — | 2026-02-24 |
|
Berard Todd
Chief Marketing Officer
|
— | $7K | 2026-04-08 |
| MOORE TIMOTHY L. | — | — | 2026-02-24 |
|
Foster Karen A.
Chief Quality and Operations
|
— | $2.0M | 2026-03-23 |
| Coste Catherine | — | — | 2026-02-24 |
|
Aebersold Sarah
Chief Human Resources Officer
|
— | $5K | 2026-03-19 |
| DuRoss Amy | — | — | 2026-02-24 |
|
Wichterman Troy
Chief Financial Officer
|
— | $12K | 2026-04-08 |
|
Werner Sean
Chief Technology Officer
|
— | $2K | 2026-03-19 |